ARGENX SE (1AE.DE) Stock Fundamental Analysis

FRA:1AE • NL0010832176

721 EUR
+3.8 (+0.53%)
Last: Feb 20, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

6

Overall 1AE gets a fundamental rating of 6 out of 10. We evaluated 1AE against 78 industry peers in the Biotechnology industry. 1AE has an excellent financial health rating, but there are some minor concerns on its profitability. 1AE is not priced too expensively while it is growing strongly. Keep and eye on this one! These ratings could make 1AE a good candidate for growth investing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • In the past year 1AE was profitable.
  • 1AE had a positive operating cash flow in the past year.
  • In the past 5 years 1AE reported 4 times negative net income.
  • In the past 5 years 1AE always reported negative operating cash flow.
1AE.DE Yearly Net Income VS EBIT VS OCF VS FCF1AE.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M

1.2 Ratios

  • 1AE has a better Return On Assets (17.84%) than 93.59% of its industry peers.
  • 1AE's Return On Equity of 21.00% is amongst the best of the industry. 1AE outperforms 92.31% of its industry peers.
  • The Return On Invested Capital of 1AE (5.36%) is better than 80.77% of its industry peers.
Industry RankSector Rank
ROA 17.84%
ROE 21%
ROIC 5.36%
ROA(3y)-5.23%
ROA(5y)-11.34%
ROE(3y)-5.76%
ROE(5y)-13.95%
ROIC(3y)N/A
ROIC(5y)N/A
1AE.DE Yearly ROA, ROE, ROIC1AE.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30

1.3 Margins

  • With an excellent Profit Margin value of 41.97%, 1AE belongs to the best of the industry, outperforming 94.87% of the companies in the same industry.
  • Looking at the Operating Margin, with a value of 15.30%, 1AE belongs to the top of the industry, outperforming 85.90% of the companies in the same industry.
  • 1AE's Gross Margin of 89.40% is amongst the best of the industry. 1AE outperforms 83.33% of its industry peers.
Industry RankSector Rank
OM 15.3%
PM (TTM) 41.97%
GM 89.4%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
1AE.DE Yearly Profit, Operating, Gross Margins1AE.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), 1AE is destroying value.
  • 1AE has more shares outstanding than it did 1 year ago.
  • 1AE has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for 1AE is higher compared to a year ago.
1AE.DE Yearly Shares Outstanding1AE.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
1AE.DE Yearly Total Debt VS Total Assets1AE.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

  • 1AE has an Altman-Z score of 30.41. This indicates that 1AE is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 30.41, 1AE belongs to the top of the industry, outperforming 94.87% of the companies in the same industry.
  • 1AE has a debt to FCF ratio of 0.14. This is a very positive value and a sign of high solvency as it would only need 0.14 years to pay back of all of its debts.
  • With an excellent Debt to FCF ratio value of 0.14, 1AE belongs to the best of the industry, outperforming 92.31% of the companies in the same industry.
  • 1AE has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
  • 1AE's Debt to Equity ratio of 0.01 is amongst the best of the industry. 1AE outperforms 84.62% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.14
Altman-Z 30.41
ROIC/WACC0.72
WACC7.43%
1AE.DE Yearly LT Debt VS Equity VS FCF1AE.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B

2.3 Liquidity

  • A Current Ratio of 5.60 indicates that 1AE has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 5.60, 1AE belongs to the top of the industry, outperforming 82.05% of the companies in the same industry.
  • A Quick Ratio of 5.27 indicates that 1AE has no problem at all paying its short term obligations.
  • 1AE's Quick ratio of 5.27 is amongst the best of the industry. 1AE outperforms 83.33% of its industry peers.
Industry RankSector Rank
Current Ratio 5.6
Quick Ratio 5.27
1AE.DE Yearly Current Assets VS Current Liabilites1AE.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 1512.50% over the past year.
  • The Revenue has grown by 64.71% in the past year. This is a very strong growth!
  • The Revenue has been growing by 94.61% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)1512.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%272.66%
Revenue 1Y (TTM)64.71%
Revenue growth 3Y63.92%
Revenue growth 5Y94.61%
Sales Q2Q%100.85%

3.2 Future

  • The Earnings Per Share is expected to grow by 103.40% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 35.36% on average over the next years. This is a very strong growth
EPS Next Y934.93%
EPS Next 2Y316.29%
EPS Next 3Y180.77%
EPS Next 5Y103.4%
Revenue Next Year95.19%
Revenue Next 2Y63.47%
Revenue Next 3Y48.27%
Revenue Next 5Y35.36%

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
1AE.DE Yearly Revenue VS Estimates1AE.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B 8B 10B
1AE.DE Yearly EPS VS Estimates1AE.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 20 40 60 80

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 68.15, the valuation of 1AE can be described as expensive.
  • Based on the Price/Earnings ratio, 1AE is valued cheaper than 80.77% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of 1AE to the average of the S&P500 Index (26.99), we can say 1AE is valued expensively.
  • Based on the Price/Forward Earnings ratio of 28.26, the valuation of 1AE can be described as expensive.
  • 1AE's Price/Forward Earnings ratio is rather cheap when compared to the industry. 1AE is cheaper than 82.05% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.06, 1AE is valued at the same level.
Industry RankSector Rank
PE 68.15
Fwd PE 28.26
1AE.DE Price Earnings VS Forward Price Earnings1AE.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, 1AE is valued a bit cheaper than 78.21% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, 1AE is valued cheaper than 80.77% of the companies in the same industry.
Industry RankSector Rank
P/FCF 169.86
EV/EBITDA 95
1AE.DE Per share data1AE.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as 1AE's earnings are expected to grow with 180.77% in the coming years.
PEG (NY)0.07
PEG (5Y)N/A
EPS Next 2Y316.29%
EPS Next 3Y180.77%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • 1AE does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ARGENX SE

FRA:1AE (2/20/2026, 7:00:00 PM)

721

+3.8 (+0.53%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)10-30
Earnings (Next)02-26
Inst Owners43.42%
Inst Owner ChangeN/A
Ins Owners0.12%
Ins Owner ChangeN/A
Market Cap44.62B
Revenue(TTM)3.60B
Net Income(TTM)1.28B
Analysts84
Price Target877.4 (21.69%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)15.16%
Min EPS beat(2)7.11%
Max EPS beat(2)23.2%
EPS beat(4)3
Avg EPS beat(4)3962.36%
Min EPS beat(4)-38.07%
Max EPS beat(4)15857.2%
EPS beat(8)5
Avg EPS beat(8)1996.71%
EPS beat(12)8
Avg EPS beat(12)1343.38%
EPS beat(16)12
Avg EPS beat(16)1012.62%
Revenue beat(2)1
Avg Revenue beat(2)3.68%
Min Revenue beat(2)-0.81%
Max Revenue beat(2)8.17%
Revenue beat(4)3
Avg Revenue beat(4)3.52%
Min Revenue beat(4)-0.81%
Max Revenue beat(4)8.17%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.99%
PT rev (3m)18.9%
EPS NQ rev (1m)-0.95%
EPS NQ rev (3m)-0.95%
EPS NY rev (1m)-0.05%
EPS NY rev (3m)6.99%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.97%
Valuation
Industry RankSector Rank
PE 68.15
Fwd PE 28.26
P/S 17.19
P/FCF 169.86
P/OCF 129.88
P/B 8.6
P/tB 8.92
EV/EBITDA 95
EPS(TTM)10.58
EY1.47%
EPS(NY)25.51
Fwd EY3.54%
FCF(TTM)4.24
FCFY0.59%
OCF(TTM)5.55
OCFY0.77%
SpS41.95
BVpS83.81
TBVpS80.8
PEG (NY)0.07
PEG (5Y)N/A
Graham Number141.25
Profitability
Industry RankSector Rank
ROA 17.84%
ROE 21%
ROCE 7.61%
ROIC 5.36%
ROICexc 14.9%
ROICexgc 16.54%
OM 15.3%
PM (TTM) 41.97%
GM 89.4%
FCFM 10.12%
ROA(3y)-5.23%
ROA(5y)-11.34%
ROE(3y)-5.76%
ROE(5y)-13.95%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.14
Debt/EBITDA 0.07
Cap/Depr 428.74%
Cap/Sales 3.12%
Interest Coverage 519.07
Cash Conversion 82.6%
Profit Quality 24.11%
Current Ratio 5.6
Quick Ratio 5.27
Altman-Z 30.41
F-Score5
WACC7.43%
ROIC/WACC0.72
Cap/Depr(3y)176.19%
Cap/Depr(5y)545.91%
Cap/Sales(3y)10.66%
Cap/Sales(5y)13.77%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1512.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%272.66%
EPS Next Y934.93%
EPS Next 2Y316.29%
EPS Next 3Y180.77%
EPS Next 5Y103.4%
Revenue 1Y (TTM)64.71%
Revenue growth 3Y63.92%
Revenue growth 5Y94.61%
Sales Q2Q%100.85%
Revenue Next Year95.19%
Revenue Next 2Y63.47%
Revenue Next 3Y48.27%
Revenue Next 5Y35.36%
EBIT growth 1Y96.67%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1529.77%
EBIT Next 3Y219.36%
EBIT Next 5Y126.87%
FCF growth 1Y140.74%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y161.76%
OCF growth 3YN/A
OCF growth 5YN/A

ARGENX SE / 1AE.DE FAQ

What is the ChartMill fundamental rating of ARGENX SE (1AE.DE) stock?

ChartMill assigns a fundamental rating of 6 / 10 to 1AE.DE.


Can you provide the valuation status for ARGENX SE?

ChartMill assigns a valuation rating of 6 / 10 to ARGENX SE (1AE.DE). This can be considered as Fairly Valued.


How profitable is ARGENX SE (1AE.DE) stock?

ARGENX SE (1AE.DE) has a profitability rating of 5 / 10.


Can you provide the financial health for 1AE stock?

The financial health rating of ARGENX SE (1AE.DE) is 8 / 10.


Can you provide the expected EPS growth for 1AE stock?

The Earnings per Share (EPS) of ARGENX SE (1AE.DE) is expected to grow by 934.93% in the next year.